Xeris Biopharma Holdings Inc (XERS)

Dec 20, 2024

Applied Therapeutics Appoints John H. Johnson as Executive Chairman - The Manila Times

Dec 20, 2024

Dec 19, 2024

Xeris Biopharma (NASDAQ:XERS) Shares Up 5.2%What's Next? - MarketBeat

Dec 19, 2024

Dec 08, 2024

Quantbot Technologies LP Purchases Shares of 15,425 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Dec 08, 2024

Dec 03, 2024

Walleye Capital LLC Purchases Shares of 1,121,738 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Dec 03, 2024

Dec 02, 2024

Connor Clark & Lunn Investment Management Ltd. Invests $237,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Dec 02, 2024

Nov 27, 2024

XERS (Xeris Biopharma Holdings) Revenue : $187.4 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

Xeris Biopharma Holdings (FRA:2B30) Other Long Term Assets : €4.9 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) Other Stockholders Equity : $0.0 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) EPS (Diluted) : $-0.44 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) GF Score : 75/100 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) Accounts Payable : $7.5 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

GSA Capital Partners LLP Sells 578,313 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Nov 26, 2024

Nov 26, 2024

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference - Business Wire

Nov 26, 2024

Nov 26, 2024

GSA Capital Partners LLP Trims Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Nov 26, 2024

Nov 25, 2024

XERS (Xeris Biopharma Holdings) Cash-to-Debt : 0.26 (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

XERS (Xeris Biopharma Holdings) Shares Outstanding (EOP) : 149.0 Mil (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

XERS (Xeris Biopharma Holdings) Other Current Liabilities : $34.8 Mil (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 17, 2024

Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long - Yahoo Finance

Nov 17, 2024

Nov 16, 2024

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): When Will It Breakeven? - Simply Wall St

Nov 16, 2024

Nov 14, 2024

HC Wainwright Forecasts Reduced Earnings for Xeris Biopharma - Defense World

Nov 14, 2024

Nov 14, 2024

Wealth Enhancement Advisory Services LLC Invests $35,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Nov 14, 2024

Nov 14, 2024

FY2024 EPS Estimate for Xeris Biopharma Raised by Analyst - Defense World

Nov 14, 2024

Nov 13, 2024

HC Wainwright Forecasts Higher Earnings for Xeris Biopharma - MarketBeat

Nov 13, 2024

Nov 13, 2024

Xeris Biopharma (NASDAQ:XERS) Rating Lowered to Neutral at Piper Sandler - Defense World

Nov 13, 2024

Nov 13, 2024

Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Nov 13, 2024

Nov 12, 2024

HC Wainwright Forecasts Weaker Earnings for Xeris Biopharma - MarketBeat

Nov 12, 2024

Nov 10, 2024

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 10, 2024

Nov 09, 2024

Earnings call: Xeris Biopharma posts record revenue in Q3 2024 - Investing.com India

Nov 09, 2024

Nov 09, 2024

Earnings call: Xeris Biopharma posts record revenue in Q3 2024 By Investing.com - Investing.com Nigeria

Nov 09, 2024

Nov 09, 2024

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 09, 2024

Nov 09, 2024

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highli - GuruFocus.com

Nov 09, 2024

Nov 08, 2024

Xeris Biopharma Reports Record Third Quarter Revenue - TipRanks

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma Holdings Inc (XERS) Quarterly 10-Q Report - Quartzy

Nov 08, 2024

Nov 08, 2024

Xeris raises revenue outlook on strong 3rd-quarter results - Crain's Chicago Business

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma Reports Third Quarter 2024 Financial Results - BioSpace

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma Holdings Inc Reports Q3 2024 Revenue of $54.3M, Beating Estimates; EPS Misses at ($0.11) - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 08, 2024

Nov 08, 2024

Xeris Biopharma (XERS) to Release Earnings on Friday - Defense World

Nov 08, 2024

Nov 01, 2024

Xeris Biopharma (XERS) Scheduled to Post Quarterly Earnings on Friday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 - BioSpace

Oct 31, 2024

Oct 25, 2024

Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive - Seeking Alpha

Oct 25, 2024

Oct 24, 2024

SG Americas Securities LLC Raises Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Oct 24, 2024

Oct 20, 2024

The Manufacturers Life Insurance Company Buys 5,291 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Oct 20, 2024

Oct 16, 2024

The Xeris Biopharma Holdings Inc (XERS) had a good session last reading, didn’t it? - US Post News

Oct 16, 2024

Oct 16, 2024

Dimensional Fund Advisors LP Sells 6,437 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Oct 16, 2024